Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Synthesis, structure-activity relationship and in vitro pharmacodynamics of A-ring modified caged xanthones in a preclinical model of inflammatory breast cancer.

Chantarasriwong O, Milcarek AT, Morales TH, Settle AL, Rezende CO Jr, Althufairi BD, Theodoraki MA, Alpaugh ML, Theodorakis EA.

Eur J Med Chem. 2019 Apr 15;168:405-413. doi: 10.1016/j.ejmech.2019.02.047. Epub 2019 Feb 20.

PMID:
30831408
2.

HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons.

Kishinevsky S, Wang T, Rodina A, Chung SY, Xu C, Philip J, Taldone T, Joshi S, Alpaugh ML, Bolaender A, Gutbier S, Sandhu D, Fattahi F, Zimmer B, Shah SK, Chang E, Inda C, Koren J 3rd, Saurat NG, Leist M, Gross SS, Seshan VE, Klein C, Tomishima MJ, Erdjument-Bromage H, Neubert TA, Henrickson RC, Chiosis G, Studer L.

Nat Commun. 2018 Oct 19;9(1):4345. doi: 10.1038/s41467-018-06486-6.

3.

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.

Putcha P, Yu J, Rodriguez-Barrueco R, Saucedo-Cuevas L, Villagrasa P, Murga-Penas E, Quayle SN, Yang M, Castro V, Llobet-Navas D, Birnbaum D, Finetti P, Woodward WA, Bertucci F, Alpaugh ML, Califano A, Silva J.

Breast Cancer Res. 2017 Apr 19;19(1):49. doi: 10.1186/s13058-017-0841-6. No abstract available.

4.

Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis.

Thorek DL, Watson PA, Lee SG, Ku AT, Bournazos S, Braun K, Kim K, Sjöström K, Doran MG, Lamminmäki U, Santos E, Veach D, Turkekul M, Casey E, Lewis JS, Abou DS, van Voss MR, Scardino PT, Strand SE, Alpaugh ML, Scher HI, Lilja H, Larson SM, Ulmert D.

Sci Transl Med. 2016 Nov 30;8(367):367ra167.

5.

HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.

Putcha P, Yu J, Rodriguez-Barrueco R, Saucedo-Cuevas L, Villagrasa P, Murga-Penas E, Quayle SN, Yang M, Castro V, Llobet-Navas D, Birnbaum D, Finetti P, Woodward WA, Bertucci F, Alpaugh ML, Califano A, Silva J.

Breast Cancer Res. 2015 Dec 8;17(1):149. doi: 10.1186/s13058-015-0658-0. Erratum in: Breast Cancer Res. 2017 Apr 19;19(1):49.

6.

Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype.

Green TM, Alpaugh ML, Barsky SH, Rappa G, Lorico A.

Biomed Res Int. 2015;2015:634865. doi: 10.1155/2015/634865. Epub 2015 Oct 27. Review.

7.

Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening.

Theodoraki MA, Rezende CO Jr, Chantarasriwong O, Corben AD, Theodorakis EA, Alpaugh ML.

Oncotarget. 2015 Aug 28;6(25):21255-67.

8.

Ex vivo treatment response of primary tumors and/or associated metastases for preclinical and clinical development of therapeutics.

Corben AD, Uddin MM, Crawford B, Farooq M, Modi S, Gerecitano J, Chiosis G, Alpaugh ML.

J Vis Exp. 2014 Oct 2;(92):e52157. doi: 10.3791/52157.

9.

The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.

Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, Cotari J, Alpaugh ML, de Stanchina E, Manova K, Li M, Bonafe M, Ceccarelli C, Taffurelli M, Santini D, Altan-Bonnet G, Kaplan R, Norton L, Nishimoto N, Huszar D, Lyden D, Bromberg J.

Neoplasia. 2013 Jul;15(7):848-62.

10.

Synthesis of purine-scaffold fluorescent probes for heat shock protein 90 with use in flow cytometry and fluorescence microscopy.

Taldone T, Gomes-DaGama EM, Zong H, Sen S, Alpaugh ML, Zatorska D, Alonso-Sabadell R, Guzman ML, Chiosis G.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5347-52. doi: 10.1016/j.bmcl.2011.07.026. Epub 2011 Jul 14.

11.

Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.

Mahooti S, Porter K, Alpaugh ML, Ye Y, Xiao Y, Jones S, Tellez JD, Barsky SH.

Oncotarget. 2010 Jun;1(2):131-47.

12.
13.

Molecular plasticity of E-cadherin and sialyl lewis x expression, in two comparative models of mammary tumorigenesis.

Pinho SS, Reis CA, Gärtner F, Alpaugh ML.

PLoS One. 2009 Aug 13;4(8):e6636. doi: 10.1371/journal.pone.0006636.

14.
15.
16.

Comparative oncological studies of feline bronchioloalveolar lung carcinoma, its derived cell line and xenograft.

Grossman DA, Hiti AL, McNiel EA, Ye Y, Alpaugh ML, Barsky SH.

Cancer Res. 2002 Jul 1;62(13):3826-33.

17.
18.
19.

Myoepithelial-specific CD44 shedding is mediated by a putative chymotrypsin-like sheddase.

Lee MC, Alpaugh ML, Nguyen M, Deato M, Dishakjian L, Barsky SH.

Biochem Biophys Res Commun. 2000 Dec 9;279(1):116-23.

PMID:
11112426
20.

Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells.

Alpaugh ML, Lee MC, Nguyen M, Deato M, Dishakjian L, Barsky SH.

Exp Cell Res. 2000 Nov 25;261(1):150-8.

PMID:
11082285
21.

The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype.

Nguyen M, Lee MC, Wang JL, Tomlinson JS, Shao ZM, Alpaugh ML, Barsky SH.

Oncogene. 2000 Jul 20;19(31):3449-59.

22.

A novel human xenograft model of inflammatory breast cancer.

Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH.

Cancer Res. 1999 Oct 15;59(20):5079-84.

23.

Supplemental Content

Loading ...
Support Center